CIBC Asset Management Inc - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 207 filers reported holding NEKTAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC Asset Management Inc ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2022$32,393
-36.5%
14,333
-10.0%
0.00%
Q3 2022$51,000
-15.0%
15,9210.0%0.00%
Q2 2022$60,000
-32.6%
15,921
-3.4%
0.00%
Q1 2022$89,000
-60.1%
16,4880.0%0.00%
-100.0%
Q4 2021$223,000
-12.9%
16,488
+17.5%
0.00%
-50.0%
Q3 2019$256,000
-48.8%
14,032
-0.2%
0.00%
-33.3%
Q2 2019$500,000
+8.9%
14,059
+3.0%
0.00%0.0%
Q1 2019$459,000
+0.9%
13,656
-1.4%
0.00%0.0%
Q4 2018$455,000
-46.0%
13,850
+0.3%
0.00%
-40.0%
Q3 2018$842,000
+24.0%
13,812
-0.7%
0.01%
+25.0%
Q2 2018$679,000
-52.1%
13,915
+4.4%
0.00%
-55.6%
Q1 2018$1,417,000
+338.7%
13,334
+146.2%
0.01%
+350.0%
Q4 2017$323,000
+19.6%
5,415
-51.8%
0.00%0.0%
Q3 2017$270,000
+33.0%
11,240
+8.4%
0.00%
+100.0%
Q2 2017$203,000
-16.5%
10,3660.0%0.00%
-50.0%
Q1 2017$243,000
+91.3%
10,3660.0%0.00%
+100.0%
Q4 2016$127,00010,3660.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2017
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders